We propose that it is potentially because DHX9 affects HCC development mostly by promoting HBV replication, while UHRF2 also influences HCC development through other classical oncogenic signaling pathways [15, 21]. The gene discussed is UHRF2; the disease is hepatocellular carcinoma.